CA
ALT icon

CoreCap Advisors’s Altimmune ALT Stock Holding History

CoreCap Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-71
Closed -$275 – 2794
2025
Q2 		$275 Hold
71
– – ﹤0.01% 2585
2025
Q1 		$355 Hold
71
– – ﹤0.01% 2778
2024
Q4 		$512 Sell
71
-100
-58% -$764 ﹤0.01% 2499
2024
Q3 		$1.05K Buy
171
+100
+141% +$677 ﹤0.01% 2263
2024
Q2 		$472 Buy
+71
New +$524 ﹤0.01% 1456

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CoreCap Advisors's ALT Position: Q3 2025 in Review

CoreCap Advisors sold out of Altimmune (ALT) in Q3 2025, closing a stake of 71 shares — an estimated $275 sold.

CoreCap Advisors first reported a position in ALT in Q2 2024 and held it in 5 quarters. The position peaked at $1.05K in Q3 2024. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • CoreCap Advisors reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • CoreCap Advisors sold 71 Altimmune shares in Q3 2025, an estimated $275.
  • CoreCap Advisors first reported a position in Altimmune in Q2 2024 and held it in 5 quarters.
  • CoreCap Advisors's Altimmune position peaked at $1.05K in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on CoreCap Advisors's 13F filing for Q3 2025, filed 22 Oct 2025.